Table 1

Characteristics of subjects included in the retrospective cohorts

BelgiumLombardy Region
Incretins (n = 22,982)NIAD (n = 345,672)P value*Incretins (n = 10,310)NIAD (n = 180,061)P value*
Baseline
 Sex<0.001<0.001
  Male13,342 (58.1)161,167 (46.6)5,829 (56.5)96,598 (53.6)
  Female9,640 (41.9)184,505 (53.4)4,481 (43.5)83,463 (46.4)
 Age-group<0.001<0.001
  <50 years6,345 (27.6)88,512 (25.6)2,507 (24.3)26,922 (15.0)
  50–59 years7,340 (31.9)79,092 (22.9)3,141 (30.5)35,534 (19.7)
  60–69 years5,555 (24.2)81,371 (23.5)2,832 (27.5)51,520 (28.6)
  ≥70 years3,742 (16.3)96,697 (28.0)1,830 (17.8)66,085 (36.7)
Follow-up
 Use of insulin<0.001<0.001
  Yes4,969 (21.6)34,082 (9.9)950 (9.2)7,719 (4.3)
  No18,013 (78.4)311,590 (90.1)9,360 (90.8)172,342 (95.7)
 Gallbladder disorder0.500.051
  Yes420 (1.8)6,532 (1.9)116 (1.1)2,435 (1.4)
  No22,562 (98.2)339,140 (98.1)10,194 (98.9)177,626 (98.6)
 Bariatric surgery<0.001
  Yes314 (1.4)5,750 (1.7)NANA
  No22,668 (98.6)339,922 (98.3)NANA
 Pancreatic surgery0.66
  Yes34 (0.1)553 (0.2)NANA
  No22,948 (99.9)345,119 (99.8)NANA
 Laparoscopic procedure0.018
  Yes75 (0.3)1,492 (0.4)NANA
  No22,907 (99.7)344,180 (99.6)NANA
  • Data are n (%). NA, not available.

  • 2 P value.